A032300 Stock Overview
Produces pharmaceutical drugs. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
KOREA PHARMA Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩15,600.00 |
| 52 Week High | ₩25,400.00 |
| 52 Week Low | ₩13,720.00 |
| Beta | 1.19 |
| 1 Month Change | -8.18% |
| 3 Month Change | -6.59% |
| 1 Year Change | -31.58% |
| 3 Year Change | -67.87% |
| 5 Year Change | n/a |
| Change since IPO | -7.42% |
Recent News & Updates
Is KOREA PHARMA (KOSDAQ:032300) A Risky Investment?
Nov 12
Optimistic Investors Push KOREA PHARMA Co., Ltd. (KOSDAQ:032300) Shares Up 29% But Growth Is Lacking
Oct 16Recent updates
Is KOREA PHARMA (KOSDAQ:032300) A Risky Investment?
Nov 12Optimistic Investors Push KOREA PHARMA Co., Ltd. (KOSDAQ:032300) Shares Up 29% But Growth Is Lacking
Oct 16KOREA PHARMA (KOSDAQ:032300) Seems To Use Debt Quite Sensibly
Mar 26What You Need To Know About KOREA PHARMA Co., Ltd.'s (KOSDAQ:032300) Investor Composition
Jan 08
Shareholder Returns
| A032300 | KR Pharmaceuticals | KR Market | |
|---|---|---|---|
| 7D | -2.7% | -0.5% | -1.9% |
| 1Y | -31.6% | 0.8% | -9.5% |
Return vs Industry: A032300 underperformed the KR Pharmaceuticals industry which returned 2.4% over the past year.
Return vs Market: A032300 underperformed the KR Market which returned -9% over the past year.
Price Volatility
| A032300 volatility | |
|---|---|
| A032300 Average Weekly Movement | 11.6% |
| Pharmaceuticals Industry Average Movement | 5.5% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.8% |
| 10% least volatile stocks in KR Market | 3.3% |
Stable Share Price: A032300's share price has been volatile over the past 3 months compared to the KR market.
Volatility Over Time: A032300's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1974 | n/a | Eun-Hee Park | www.koreapharma.co.kr |
KOREA PHARMA Co., Ltd. . produces pharmaceutical drugs. The company offers amino acid, antibiotic, antidotal, antiepileptic, antihistamine, anti-inflammatory, antimicrobial, antiplatelet, circulatory system, CNS, dermatological, endocrine, gastrointestinal, hepatic, hormonal, respiratory, sympathomimetic, skeltal muscle relaxants, and specialty drugs, as well as multivitamins, and vitamin B1, etc. KOREA PHARMA Co., Ltd.
KOREA PHARMA Co., Ltd. Fundamentals Summary
| A032300 fundamental statistics | |
|---|---|
| Market cap | ₩170.14b |
| Earnings (TTM) | ₩3.00b |
| Revenue (TTM) | ₩79.80b |
56.7x
P/E Ratio2.1x
P/S RatioIs A032300 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A032300 income statement (TTM) | |
|---|---|
| Revenue | ₩79.80b |
| Cost of Revenue | ₩45.12b |
| Gross Profit | ₩34.68b |
| Other Expenses | ₩31.68b |
| Earnings | ₩3.00b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 275.06 |
| Gross Margin | 43.46% |
| Net Profit Margin | 3.76% |
| Debt/Equity Ratio | 30.4% |
How did A032300 perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yieldn/a
Payout RatioDoes A032300 pay a reliable dividends?
See A032300 dividend history and benchmarks| KOREA PHARMA dividend dates | |
|---|---|
| Ex Dividend Date | Dec 27 2024 |
| Dividend Pay Date | Apr 28 2025 |
| Days until Ex dividend | 1 day |
| Days until Dividend pay date | 123 days |
Does A032300 pay a reliable dividends?
See A032300 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/25 04:10 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
KOREA PHARMA Co., Ltd. is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jongsun Park | Eugene Investment & Securities Co Ltd. |
| Taehee Kim | Mirae Asset Securities Co., Ltd. |